Evidence map›Paper›PMID 22797725›Full record

ArticleNature genetics2012

Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population.

Jing Dong, Zhibin Hu, Chen Wu, Huan Guo, Baosen Zhou, Jiachun Lv, Daru Lu, Kexin Chen, Yongyong Shi, Minjie Chu and 41 more

Abstract read
In one paragraph

Article in Nature genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Single nucleotide variants in lung cancer.Chinese medical journal pulmonary and critical care medicine · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors.

Jing DongDepartment of Epidemiology and Biostatistics and Ministry of Education (MOE) Key Lab for Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China.
Zhibin Hu
Chen Wu
Huan Guo
Baosen Zhou
Jiachun Lv
Daru Lu
Kexin Chen
Yongyong Shi
Minjie Chu
Cheng Wang
Ruyang Zhang
Juncheng Dai
Yue Jiang
Songyu Cao
Zhenzhen Qin
Dianke Yu
Hongxia Ma
Guangfu Jin
Jianhang Gong
Chongqi Sun
Xueying Zhao
Zhihua Yin
Lei Yang
Zhiqiang Li
Qifei Deng
Jiucun Wang
Wei Wu
Hong Zheng
Guoquan Zhou
Hongyan Chen
Peng Guan
Zhihang Peng
Yijiang Chen
Yongqian Shu
Lin Xu
Xiangyang Liu
Li Liu
Pin Xu
Baohui Han
Chunxue Bai
Yuxia Zhao
Haibo Zhang
Ying Yan
Christopher I Amos
Feng Chen
Wen Tan
Li Jin
Tangchun Wu
Dongxin Lin
Hongbing Shen

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
Translating Molecular and Clinical Data to Population Lung Cancer Risk AssessmentU19CA203654 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher I. Amos, Rayjean J. Hung · 2017 to 2026
$23.7M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
Genetic Susceptibility for Lung Cancer in African AmericansR01CA141716 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2009 to 2009
$398k
NCI NIH HHS P30 CA022453NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA141716NCI NIH HHS R35 CA197449NCI NIH HHS U19 CA148127NCI NIH HHS U19 CA203654
6 · The paper itself

Abstract

To find additional susceptibility loci for lung cancer, we tested promising associations from our previous genome-wide association study (GWAS) of lung cancer in the Chinese population in an extended validation sample size of 7,436 individuals with lung cancer (cases) and 7,483 controls. We found genome-wide significant (P < 5.0 × 10(-8)) evidence for three additional lung cancer susceptibility loci at 10p14 (rs1663689, close to GATA3, P = 2.84 × 10(-10)), 5q32 (rs2895680 in PPP2R2B-STK32A-DPYSL3, P = 6.60 × 10(-9)) and 20q13.2 (rs4809957 in CYP24A1, P = 1.20 × 10(-8)). We also found consistent associations for rs247008 at 5q31.1 (IL3-CSF2-P4HA2, P = 7.68 × 10(-8)) and rs9439519 at 1p36.32 (AJAP1-NPHP4, P = 3.65 × 10(-6)). Four of these loci showed evidence for interactions with smoking dose (P = 1.72 × 10(-10), P = 5.07 × 10(-3), P = 6.77 × 10(-3) and P = 4.49 × 10(-2) for rs2895680, rs4809957, rs247008 and rs9439519, respectively). These results advance our understanding of lung cancer susceptibility and highlight potential pathways that integrate genetic variants and smoking in the development of lung cancer.

Indexed as

Asian PeopleCase-Control StudiesChinaGATA3 Transcription FactorGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansLung NeoplasmsMuscle ProteinsNerve Tissue ProteinsPolymorphism, Single NucleotideProtein Phosphatase 2SmokingSteroid HydroxylasesVitamin D3 24-HydroxylaseCYP24A1 protein, humanDPYSL3 protein, humanGATA3 protein, humanGATA3 Transcription FactorMuscle ProteinsNerve Tissue ProteinsPPP2R2B protein, humanProtein Phosphatase 2Steroid HydroxylasesVitamin D3 24-Hydroxylase

Identifiers

PMID22797725
PMCPMC6628171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.